Science Journal

Chronic Depression

After SSRIs: Yale Scientists Map New Pathway To Treat Depression

By Lisa Chedekel | October 4, 2012

For a decade, scientists have been trying to explain why a single dose of the drug ketamine manages to do what typical antidepressants don’t: Lift symptoms of chronic depression within hours, rather than weeks, in treatment-resistant patients.